AllianceBernstein’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-42,088
| Closed | -$5.75M | – | 3186 |
|
|
2018
Q2 | $5.75M | Sell |
42,088
-153,038
| -78% | -$13.9M | ﹤0.01% | 1178 |
|
|
2018
Q1 | $15.4M | Sell |
195,126
-109,165
| -36% | -$8.06M | 0.01% | 839 |
|
|
2017
Q4 | $20.8M | Sell |
304,291
-368,544
| -55% | -$19.1M | 0.01% | 774 |
|
|
2017
Q3 | $27M | Sell |
672,835
-7,345
| -1% | -$283K | 0.02% | 666 |
|
|
2017
Q2 | $27M | Sell |
680,180
-108,680
| -14% | -$3.98M | 0.02% | 661 |
|
|
2017
Q1 | $25.4M | Buy |
788,860
+220,236
| +39% | +$5.49M | 0.02% | 660 |
|
|
2016
Q4 | $10.1M | Buy |
568,624
+540,604
| +1,929% | +$11.6M | 0.01% | 908 |
|
|
2016
Q3 | $654K | Hold |
28,020
| – | – | ﹤0.01% | 2420 |
|
|
2016
Q2 | $523K | Buy |
28,020
+9,000
| +47% | +$163K | ﹤0.01% | 2513 |
|
|
2016
Q1 | $346K | Sell |
19,020
-600
| -3% | -$9.67K | ﹤0.01% | 2538 |
|
|
2015
Q4 | $413K | Sell |
19,620
-2,200
| -10% | -$42.4K | ﹤0.01% | 2515 |
|
|
2015
Q3 | $403K | Sell |
21,820
-1,880
| -8% | -$46.9K | ﹤0.01% | 2563 |
|
|
2015
Q2 | $802K | Sell |
23,700
-29,890
| -56% | -$1.2M | ﹤0.01% | 2395 |
|
|
2015
Q1 | $2.58M | Sell |
53,590
-37,790
| -41% | -$1.71M | ﹤0.01% | 1546 |
|
|
2014
Q4 | $2.03M | Buy |
91,380
+72,480
| +383% | +$1.67M | ﹤0.01% | 1744 |
|
|
2014
Q3 | $358K | Buy |
18,900
+3,300
| +21% | +$78.7K | ﹤0.01% | 2611 |
|
|
2014
Q2 | $421K | Buy |
+15,600
| New | +$395K | ﹤0.01% | 2566 |
|
AllianceBernstein's FMI Position: Q3 2018 in Review
AllianceBernstein sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 42,088 shares — an estimated $5.75M sold.
AllianceBernstein first reported a position in FMI in Q2 2014 and held it in 17 quarters. The position peaked at $27M in Q3 2017. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- AllianceBernstein reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- AllianceBernstein sold 42,088 Foundation Medicine, Inc. shares in Q3 2018, an estimated $5.75M.
- AllianceBernstein first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 17 quarters.
- AllianceBernstein's Foundation Medicine, Inc. position peaked at $27M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on AllianceBernstein's 13F filing for Q3 2018, filed 8 Nov 2018.